由 洪業晃 著作 · 2006 · 被引用 1 次 — Interferon combined ribavirin therapy in chronic hepatitis C was a standard principle except non-responders or relapse's. Stronger Neo-Minophagen C (SNMC) is a ...
Acute hepatitis B virus (HBV) is one of the most common causes of fulminant hepatitis, especially in the endemic area. ... SNMC were used for total 15 days.
由 L Zhang 著作 · 2000 · 被引用 21 次 — SNMC was proved to be safe with minimal side effects. Introduction. Hepatitis B virus (HBV) is the leading cause of liver disease in China, threatening ...
由 K Reddyvari 著作 · 2015 · 被引用 1 次 — There is increasing evidence to indicate the therapeutic efficacy of SNMC in normalizing liver function tests (LFT) in patients with acute hepatitis. Objectives ...
OBJECTIVE: To compare the efficacy and safety of Stronger Neo-Minophagen C (SNMC) in the treatment of chronic hepatitis B. METHODS: We searched MEDLINE, EMBASE, ...
SNMC (Stronger Neo-Minophagen C ) for Acute Hepatitis Post Transarterial Chemoembolization Therapy. The safety and scientific validity of this study is the ...
由 H Kumada 著作 · 2002 · 被引用 264 次 — Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma.
由 WC Huang 著作 · 2023 · 被引用 1 次 — Stronger Neo-Minophagen C (SNMC) has demonstrated benefits in patients with hepatitis. We aimed to determine its usefulness in post-TACE ...
2021年6月10日 — 1, 黃文杰(1), Benefits of SNMC (Stronger Neo-Minophagen C ) for acute hepatitis post transarterial chemoembolization therapy on hepatoma patient.
